SPIOMET4HEALTH project | Clinical trials

PCOS affects between 5 and 10% of women of reproductive age and can cause increased body hair and acne, irregular menstrual periods, and fertility problems. It is the most common endocrine disorder in women of reproductive age but is still one of the most unknown pathologies among the general population. It can also lead to the development of other diseases such as type 2 diabetes, cancer before menopause, and anxiety or depression, which can greatly impact the quality of life for women affected by the condition.

PCOS affects between 5 and 10% of women of reproductive age and can cause increased body hair and acne, irregular menstrual periods, and fertility problems. It is the most common endocrine disorder in women of reproductive age but is still one of the most unknown pathologies among the general population. It can also lead to the development of other diseases such as type 2 diabetes, cancer before menopause, and anxiety or depression, which can greatly impact the quality of life for women affected by the condition.
April 17, 2023

You can now participate in the clinical trial for polycystic ovary syndrome (PCOS) in Norway, Denmark, Italy, Austria, Turkey and Spain!

The clinical trials is aimed at girls and women with Polycystic Ovary Syndrome (PCOS) and who fulfill the following criteria:

✔ 12-24 years

✔ Irregular periods

✔ High amount of body hair

Spiomet4Health aims to provide a novel treatment for adolescent girls and young adult women with Polycystic Ovary Syndrome (PCOS). At ASPHALION, we are proud regulatory partners of this EU-funded HORIZON project. We are committed to improving women’s health!

➥ Come join Spiomet4Health clinicaltrials!

ℹ Further information ⬇

 

You can now participate in the clinical trial for Polycystic Ovary Syndrome (PCOS) in Norway, Denmark, Italy, Austria, Turkey and Spain

Search News & Events

  • Filter by category

Share

Related news and events

NABIHEAL project | Progress meeting

ASPHALION is proud member of the NABIHEAL EU-funded project consortium, ensuring the compliance with regulatory standards during the pre-clinical development of the innovative NABIHEAL product development to facilitate future fast translation to clinical setting

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting